NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

PGSD, Thanks for sharing Caravello's post!

The CHM Meeting May Be About Coordination, Not Permission

With the Commission on Human Medicines reportedly convening in the next 48 hours, many investors expect a yes or no vote on DCVax approval. But that may not be the right question anymore.

CHM could now be advising on implementation, not adjudication.

If DCVax is already legal to deploy under SI 87 and the Modular Law, then CHM’s task may be to align the regulatory interpretation with this new legal framework. Their vote might confirm procedural compliance, outline guidance for modular scaling, or offer clarity to NHS Trusts and physicians preparing to adopt the platform.

The question is no longer “Will they approve it?” It’s “How will it run now that approval isn’t required?”